Harry L. Leider - Jun 28, 2023 Form 4/A Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role
Chief Executive Officer, Director
Signature
/s/ Harry L. Leider
Stock symbol
OCEL
Transactions as of
Jun 28, 2023
Transactions value $
$10,440
Form type
4/A
Date filed
12/21/2023, 04:01 PM
Date Of Original Report
Jun 30, 2023
Previous filing
Jun 9, 2023
Next filing
Dec 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCEL Common Stock Purchase $5.44K +549K $0.01 549K Jun 28, 2023 See footnote F1
transaction OCEL Common Stock Purchase $5K +500K +91% $0.01 1.05M Jun 29, 2023 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by the Harry L. Leider Revocable Trust of which the Reporting Person is the Trustee. The purpose of this Amendment is to correct the purchase price for the shares purchased on June 28, 2023.